Health Sciences Group Inc (HESG)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0020 +0.0019 (+1900.00%) 02/29/24 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0020 unch (unch) 15:42 ET
for Thu, Feb 29th, 2024
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2017 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | N/A | N/A | 20 | 240 | 260 |
Receivables | N/A | N/A | 7 | 130 | 1,850 |
Inventories | N/A | N/A | 90 | 60 | 2,580 |
Other current assets | 0 | 0 | 13 | 330 | 110 |
TOTAL | $N/A | $N/A | $130 | $760 | $4,800 |
Non-Current Assets | |||||
PPE Net | N/A | N/A | 0 | 30 | 1,410 |
Investments And Advances | 0 | 0 | 0 | 0 | 90 |
Other Non-Current Assets | 0 | 0 | 4,020 | 3,600 | 4,580 |
TOTAL | $N/A | $N/A | $4,020 | $3,630 | $6,080 |
Total Assets | $N/A | $N/A | $4,150 | $4,400 | $10,900 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | N/A | N/A | 310 | 0 | 0 |
Accounts payable and accrued liabilities | 0 | 0 | 270 | 820 | 2,760 |
Accrued Expenses | N/A | N/A | 880 | 560 | 0 |
Other current liabilities | N/A | N/A | 3,540 | 0 | 160 |
TOTAL | $N/A | $N/A | $5,020 | $1,500 | $6,230 |
Non-Current Liabilities | |||||
Long Term Debt | N/A | N/A | 0 | 0 | 120 |
aiOther Non-Current Liabilities | 0 | 0 | 4,030 | 7,280 | 3,610 |
TOTAL | $N/A | $N/A | $4,030 | $7,280 | $3,730 |
Total Liabilities | $N/A | $N/A | $9,060 | $8,780 | $9,980 |
Shareholders' Equity | |||||
Common Shares | N/A | N/A | 20 | 10 | 10 |
Retained earnings | N/A | N/A | -28,670 | -22,910 | -12,470 |
Other shareholders' equity | 0 | 0 | -1,000 | 520 | -570 |
TOTAL | $N/A | $N/A | $-4,910 | $-4,380 | $910 |
Total Liabilities And Equity | $0 | $0 | $4,150 | $4,400 | $10,890 |